EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension

Christopher Nass Rudzitis, Monika Lakk, Ayushi Singh, Sarah N Redmon, Denisa Kirdajová, Yun-Ting Tseng, Michael L De Ieso, W Daniel Stamer, Samuel Herberg, David Krizaj iD

eLife · 2025

DOI: 10.7554/elife.104894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Christopher Nass Rudzitis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Salt Lake City, United States. Hauptthemen laut MEDLINE: TRPV Cation Channels, Transforming Growth Factor beta2, Ocular Hypertension, Trabecular Meshwork. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The risk for developing primary open-angle glaucoma (POAG) correlates with the magnitude of ocular hypertension (OHT) and the concentration of transforming growth factor-β2 (TGFβ2) in the aqueous humor. Effective treatment of POAG requires a detailed understanding of the interaction between pressure sensing mechanisms in the trabecular meshwork (TM) and biochemical risk factors. Here, we employed molecular, optical, electrophysiological, and tonometric strategies to establish the role of TGFβ2 in transcription and functional expression of mechanosensitive channel isoforms alongside studies of TM contractility in biomimetic hydrogels and intraocular pressure (IOP) regulation in a mouse model of TGFβ2-induced OHT. TGFβ2 upregulated expression of Trpv4 and Piezo1 transcripts and time-dependently augmented functional TRPV4 activation. TRPV4 agonists induced contractility of TM-seeded hydrogels, whereas pharmacological inhibition suppressed TGFβ2-induced hypercontractility and abrogated OHT in eyes overexpressing TGFβ2. Trpv4 -deficient mice resisted TGFβ2-driven increases in IOP, but nocturnal OHT was not additive to TGFβ-evoked OHT. Our study establishes the fundamental role of TGFβ as a modulator of mechanosensing in nonexcitable cells, identifies the TRPV4 channel as the final common mechanism for TM contractility and circadian and pathological OHT, and offers insights for future treatments that can lower IOP in the sizeable cohort of hypertensive glaucoma patients that resist current treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsTransforming Growth Factor beta2Ocular HypertensionTrabecular MeshworkAnimalsMiceIntraocular PressureHumansDisease Models, AnimalIon ChannelsGlaucoma, Open-AngleMice, KnockoutMice, Inbred C57BL

Stichwörter der Autor:innen

TGFB2TRPV4calciumcircadian rhythmcontractilityelectrophysiologyglaucomahuman (cells)intraocular pressureknockout micemouseneuroscience

Substanzen

TRPV Cation ChannelsTransforming Growth Factor beta2Trpv4 protein, mousePiezo1 protein, mouseIon Channels

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, Salt Lake City, United States.
  • Department of Neurobiology, University of Utah, Salt Lake City, United States.
  • Department of Ophthalmology and Visual Sciences, Syracuse, United States.
  • Department of Cell and Developmental Biology, SUNY Upstate Medical University, Syracuse, United States.
  • Department of Ophthalmology, Duke Eye Center, Duke University, Durham, United States.
  • Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, United States.

ORCID-Profile: David Krizaj

Förderung

  • NEI NIH HHS
  • NIH HHS
  • National Eye Institute
  • Crandall Glaucoma Initiative
  • Stauss-Ranking Foundation
  • Research to Prevent Blindness
  • National Institutes of Health

Zitieren

APA

Rudzitis, C. N., Lakk, M., Singh, A., Redmon, S. N., Kirdajová, D., Tseng, Y. T., De Ieso, M. L., Stamer, W. D., Herberg, S., & Krizaj, D. (2025). TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension. eLife. https://doi.org/10.7554/elife.104894

Vancouver

Rudzitis CN, Lakk M, Singh A, Redmon SN, Kirdajová D, Tseng YT, et al. TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension. eLife. 2025. doi:10.7554/elife.104894

BibTeX
@article{Rudzitis2025,
  author = {Rudzitis, Christopher Nass and Lakk, Monika and Singh, Ayushi and Redmon, Sarah N and Kirdajová, Denisa and Tseng, Yun-Ting and De Ieso, Michael L and Stamer, W Daniel and Herberg, Samuel and Krizaj, David},
  title = {TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.104894}
}
Kostenlos starten →